Argenx
ARGX
#534
Rank
โ‚ฌ36.80 B
Marketcap
601,86ย โ‚ฌ
Share price
-0.35%
Change (1 day)
87.05%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total assets

Total assets on the balance sheet as of June 2024 : โ‚ฌ4.62 Billion

According to Argenx 's latest financial reports the company's total assets are โ‚ฌ4.62 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Argenx - Total assets on balance sheet (from 2013 to 2020)

Total assets by year

Year Total assets Change
2020-12-31โ‚ฌ2.27 B41.56%
2019-12-31โ‚ฌ1.61 B143.35%
2018-12-31โ‚ฌ0.66 B48.7%
2017-12-31โ‚ฌ0.44 B300.02%
2016-12-31โ‚ฌ0.11 B121.37%
2015-12-31โ‚ฌ50.25 M-29.37%
2014-12-31โ‚ฌ71.14 M105.99%
2013-12-31โ‚ฌ34.53 M50.63%
2012-12-31โ‚ฌ22.92 M-28.21%
2011-12-31โ‚ฌ31.94 M160.5%
2010-12-31โ‚ฌ12.26 M